Advisory Services Network, LLC Veru Inc. Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $25,904 - $42,792	-4,398 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$6.78 - $9.89 $109,171 - $159,248	-16,102 Reduced 78.55%	4,398 $38,000
Q2 2021 Aug 12, 2021	SELL	$7.24 - $11.2 $132,130 - $204,400	-18,250 Reduced 47.1%	20,500 $165,000
Q1 2021 May 24, 2021	BUY	$8.05 - $20.78 $247,537 - $638,985	30,750 Added 384.38%	38,750 $418,000
Q4 2020 Feb 09, 2021	BUY	$2.36 - $9.99 $1,770 - $7,492	750 Added 10.34%	8,000 $69,000
Q3 2020 Nov 16, 2020	BUY	$2.58 - $3.36 $18,705 - $24,360	7,250 New	7,250 $19,000
Q2 2020 Aug 10, 2020	SELL	$3.01 - $4.02 $21,822 - $29,144	-7,250 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$1.86 - $3.35 $13,485 - $24,287	7,250 New	7,250 $24,000

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.